secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lineage Cell Therapeutics, Inc. (LCTX)
CIK:        0000876343
Form:       8-K
Filed at:   2026-03-11T23:59:59+00:00
Accession:  0001193125-26-101167
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lineage Cell Therapeutics files prospectus supplement for up to $60M ATM offering
--------------------------------------------------------------------------------

- Offers up to $60,000,000 of common shares in at-the-market offering through B. Riley Securities.
- Prior sales under the same shelf registration total $22,583,664 in aggregate gross proceeds.
- Prospectus supplement dated March 11, 2026 supplements shelf registration effective May 14, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/876343/000119312526101167/0001193125-26-101167-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/876343/000119312526101167/lctx-20260311.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-101167

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer